首页> 外文期刊>Biotechnology Journal >Ethical questions concerning research on human embryos, embryonic stem cells and chimeras
【24h】

Ethical questions concerning research on human embryos, embryonic stem cells and chimeras

机译:有关人类胚胎,胚胎干细胞和嵌合体研究的伦理问题

获取原文
获取原文并翻译 | 示例
           

摘要

Research using human embryos and embryonic stem cells is viewed as important for various reasons. Apart from questions concerning legal regulations, numerous ethical objections are raised pertaining to the use of surplus embryos from reproductive medicine as well as the creation of embryos and stem cells through cloning. In the hopes of avoiding ethical problems, alternatives have been proposed including the extraction of egg cells from "dead" embryos derived from in vitro fertilization procedures, the extraction of pluripotent stem cells from blastocysts, technologies such as "altered nuclear transfer" (ANT) and "oocyte-assisted reprogramming" (ANT-OAR) as well as parthenogenesis. Initial ethical assessments show that certain questions pertain ing to such strategies have remained unanswered. Furthermore, with the help of new or more differentiated biotech-nological procedures, it is possible to create chimeras and hybrids in which human and non-human cells are combined. Human-animal chimeras, in which gametes or embryonic tissue have been mixed with embryonic or adult stem cells, demonstrate a different "quality" and "degree of penetration" from those produced in previous experiments. Not only does this have consequences regarding questions of patentability, this situation also raises fundamental questions concerning the human being's self image, the concept of person, identity and species and the moral rights and duties that are connected with such concepts. There is a need for legal regulation, on the national as well as the international level.
机译:由于各种原因,使用人类胚胎和胚胎干细胞进行研究被认为很重要。除了有关法律法规的问题外,关于使用生殖医学中的多余胚胎以及通过克隆产生胚胎和干细胞的问题,在伦理上也提出了许多反对意见。为了避免出现道德问题,已提出了替代方案,包括从体外受精程序衍生的“死”胚胎中提取卵细胞,从胚泡中提取多能干细胞,诸如“改变的核移植”(ANT)之类的技术。和“卵母细胞辅助重编程”(ANT-OAR)以及孤雌生殖。初步的道德评估表明,与此类策略有关的某些问题尚未得到解答。此外,借助于新的或更差异化的生物技术程序,有可能产生嵌合体和杂种,其中人和非人细胞结合在一起。配子或胚胎组织已与胚胎或成体干细胞混合的人-动物嵌合体显示出与先前实验中所产生的不同的“质量”和“穿透度”。这不仅对可专利性问题产生影响,而且这种情况还提出了有关人的自我形象,人,身份和种类的概念以及与这些概念有关的精神权利和义务的基本问题。在国家和国际一级都需要法律法规。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号